Reuters: Global Markets: Amylin shares rise as it seeks buyers

Reuters: Global Markets Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com

Amylin shares rise as it seeks buyers Apr 23rd 2012, 13:29 Mon Apr 23, 2012 9:29am EDT (Reuters) - Shares of Amylin Pharmaceuticals Inc (AMLN.O) rose 12 percent in premarket trade following a Reuters report that the drug maker is seeking buyers after it spurned a $3.5 billion buyout offer from Bristol-Myers Squibb Co (BMY.N). Amylin, which makes diabetes drugs Byetta and Bydureon, has hired Credit Suisse (CSGN.VX) and Goldman Sachs (GS.N) as its financial advisers and Skadden Arps as its legal adviser, sources familiar with the situation told Reuters on Sunday. Potential buyers for Amylin could include AstraZeneca Plc (AZN.L), Merck & Co (MRK.N) and Takeda Pharmaceutical Co Ltd (4502.T), according to analysts. Amylin has been considered a possible takeover target for some time. Pressure on Amylin increased after news of the failed Bristol-Myers bid leaked and prompted Carl Icahn to turn his sights on the company. Icahn, whose 8.94 percent stake has made him Amylin's third-largest shareholder, has called for a sale and sued the company, demanding the right to nominate directors. Amylin shares were up $2.74 at $25.66 in trading before the bell on Monday. They closed at $22.92 on Friday on the Nasdaq. (Reporting by Anand Basu in Bangalore; Editing by Supriya Kurane) Link this Share this Digg this Email Reprints

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions